Viking Therapeutics Inc Cash Flow-to-Debt Ratio
Viking Therapeutics Inc cash flow-to-debt ratio. Viking Therapeutics Inc (VKTX) has a Cash Flow-to-Debt Ratio of -1.10x as of June 2026, meaning its operating cash flow of $-125.17 Million could theoretically repay -1% of its total liabilities ($113.58 Million) in one year. See VKTX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Viking Therapeutics Inc (2012–2025)
Cash flow-to-debt ratio of Viking Therapeutics Inc from 2012 to 2025. Historical debt coverage capacity for Viking Therapeutics Inc across 14 annual periods. Check VKTX operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Viking Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Viking Therapeutics Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Viking Therapeutics Inc. For the full cash flow conversion analysis, see Viking Therapeutics Inc (VKTX) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.64x | $-278.69 Million | $76.67 Million | ▼ -16.1% |
| 2024 | -3.13x | $-87.79 Million | $28.04 Million | ▲ +14.4% |
| 2023 | -3.66x | $-73.38 Million | $20.07 Million | ▼ -75.3% |
| 2022 | -2.09x | $-48.40 Million | $23.21 Million | ▲ +61.5% |
| 2021 | -5.42x | $-47.59 Million | $8.78 Million | ▼ -202.7% |
| 2020 | -1.79x | $-21.78 Million | $12.16 Million | ▲ +48.4% |
| 2019 | -3.47x | $-24.75 Million | $7.14 Million | ▲ +15.6% |
| 2018 | -4.11x | $-18.75 Million | $4.56 Million | ▼ -141.1% |
| 2017 | -1.70x | $-14.76 Million | $8.66 Million | ▲ +0.0% |
| 2016 | -1.71x | $-11.07 Million | $6.49 Million | ▼ -31.1% |
| 2015 | -1.30x | $-8.73 Million | $6.71 Million | ▼ -1957.0% |
| 2014 | -0.06x | $-1.59 Million | $25.17 Million | ▲ +65.2% |
| 2013 | -0.18x | $-78.23K | $431.00K | ▼ -9467.5% |
| 2012 | 0.00x | $-200.00 | $105.42K | — |